| Tag | Content |
|---|
EnhancerAtlas ID | HS034-15164 |
Organism | Homo sapiens |
Tissue/cell | ECC-1 |
Coordinate | chr19:36193000-36193820 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| NFYA | MA0060.3 | chr19:36193359-36193370 | GGCCAATCAGA | + | 6.02 | | NFYB | MA0502.1 | chr19:36193471-36193486 | GAGCCAGCCAATCAG | + | 6.04 | | TFAP2A | MA0003.3 | chr19:36193108-36193119 | CGCCTCAGGCT | + | 6.14 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_19716 | chr19:36192977-36193968 | CD4p_CD25-_Il17p_PMAstim_Th17 | | SE_59463 | chr19:36184851-36210443 | Ly3 | | SE_61403 | chr19:36184821-36210454 | HBL1 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH19I035701 | chr19 | 36192703 | 36194302 |
|
Enhancer Sequence | GTGATCTGCC CGCCTTAGCC TCCCAAAGTG CTGGGATTAC AGGCGTGAGC CACCACGTCC 60
GGCCCCTTCC CCCATTTTAG CGGTTTCGCT CCCTATCGGG GCCAGGGACG CCTCAGGCTG 120
TCTCGGTCAG GACCTACAGC TCCGGTTGTT GTCCCAGGCT CTTCCGCGAG GTGCTCTCCT 180
GTCTCCTGAC CACCCCCATT CCTCCCCACT CCAGCTCCTC AGCGAGCGGC TGCGAAGGAC 240
GCGCACAACA ACACTCCGCG CAGCGGGAAG GTACCGAACT CGCATCGCAG CCTGAAACTG 300
CTCAACTAAG CTCCCGCCCC GCTGCTCTCT GGTCAATCTA AAGCGAAGAC GAGCCTTAGG 360
GCCAATCAGA AGCGACAGCG GTGGAGTCAT GCCCGCCTGC TTGAGGCGCC CTGGCGTCTC 420
ATTGGCTATG CTTGAGAACG AATCCCAGGC TAAGCCACTT AGAAAGGAGC GGAGCCAGCC 480
AATCAGCGGT GCAACCGCCG CGGGGGCCGG GCCAGAAGCC CCGCAGACAA GCACCTCGGG 540
AGACTGGCGA GGGGCGAGCT CGCAGCTTGT TAGCCCCGAA GCCCTGCCCA GGGGGAAACC 600
CTGCTGGAGG GAGTCTAACC CCCGGGCCAG TTAATGTTGG GGCAGCGCAA TCGGCCGTTC 660
CCTCTGCGGT ATGGTTGGAG GTGGGAGTGC TGACACGTCC GCGCGCAGTT ACTCCTGGCT 720
GAGCATACAG TCGAGGTGGC AGTGGGAATT GGAAGTGCAA GTGTCACGCT GCCAATCACG 780
GGGCAAGGCA CTGCCCCCCT CTTGTGTCTT TCCTGTCCCT 820
|
